Employing more than 5,000 professionals at 15 international plant sites, we are the leading international supplier of active pharmaceutical ingredients (APIs) with the industry’s broadest portfolio of more than 350 products. Our leadership in cutting-edge development, large-scale production capacity and global support, make us your ideal API partner of choice.
Teva api by the numbers
Our Core Strengths
Our commitment to you is expressed through the following:
At Teva api, we believe that great things come from great partnerships. We thrive on close collaboration with our customers and are committed to providing them with exceptional experiences. Partnering together, we help our customers bring their high-quality products to market efficiently and effectively.
As a Teva api customer, we will provide you with a dedicated team of experts who will work with you throughout the project lifecycle. This team includes an account manager, a customer experience expert, and a supply chain representative. Read more
For over 85 years, quality has been the cornerstone upon which Teva api is built, enabling us to consistently deliver top-quality products and services. Our commitment to quality is uncompromising. Our stringent policies and procedures ensure we are in full compliance with regulatory requirements, environmental standards and technological trends. You can rest assured that you are consistently receiving high-quality, safe and effective products.
These centers develop synthetic and semi-synthetic (fermentation) products, steroids, vitamins, and complex generic drug substances (such as oligopeptides, polymers, oligonucleotides, inorganic, and metal complexes). These products are used in several therapeutic areas, from oncology to respiratory, and more.
Our significant investment in research and development generates a steady flow of API compounds, providing customers with early launch opportunities. We have significant IP capabilities and are constantly innovating in order to implement new technologies and support highly-complex products.
We are also dedicated to improving process efficiency and automation, enabling customers to reduce costs and remain competitive in the global marketplace.
With 70 professionals supporting the regulatory activities in all markets globally, the Regulatory Affairs department’s commitment is three-fold: to submit high-quality DMFs including all data and registration documents needed; to turn experience and data in to knowledge by analyzing regulatory trends and continuously improving the content for submissions; and to support all customers utilizing our global coverage and experience.
Dr. Augusto Canavesi is Head of New Products Management. He is globally responsible for the development strategy of the new products to be included in Teva api portfolio.
He joined Teva api in 2005 as senior chemist and then took several positions increasing his responsibilities: in 2007 as head of Chemistry in Italy R&D, in 2013 as head of Italy R&D, in 2016 as head of Italy, Mexico and Czech Republic R&D and from 2018 in his current global R&D role.
Dr. Augusto Canavesi received his PhD from the University of Milan in 1996 and after a 2 year experience as a post-doc in Minneapolis at the University of Minnesota, he started his career in the industry as a process chemist. His activity has always been devoted to development of efficient and robust processes for the production of new APIs at industrial scale, mainly related to highly potent APIs (HPAPIs) from anticancer to respiratory drugs.
He is the co-author of 20 research publications and several international patent applications in the area of polymorphism and process chemistry.
Olga Progrebinsky has a Ph.D. degree in Organic Chemistry from Tel-Aviv University and has worked in Teva api’s regulatory affairs group for 13 years and is currently the head of global regulatory affairs at Teva api. The Teva api global RA team is spread across 10 countries and provides regulatory support to all Teva api sites and all Teva api customers worldwide.Back
Maytal Piran is Director of Physical R&D. She leads the solid state global team of product managers and researchers, specializing in API crystal forms, particle & powder properties. Maytal joined the company in 2008, and has since held multiple roles, including: Director of Teva API Physical R&D, Israel; Manager of Particles & Powder Properties Characterization Group; and Project Manager, Physical R&D.
Maytal has a PhD in Medicine Chemistry from Bar-Ilan University, specializing in solid-state chemistry and nanotechnology.
Liron Shakoof is Director of Launch Readiness and Planning & Control for the global MS&T unit. Liron has been at Teva since 2010, holding various positions in the Israel manufacturing sites of Teva’s pharma operations, including in the Supply Chain, and Quality and Planning teams.
Liron holds a BSc in Material Engineering from Ben-Gurion University of the Negev and an MBA in Technology Companies Management from the College of Management.Back
Bertil Wagensveld is Head of Global Logistics & Commercial Supply Chain at Teva api. Bertil has been at Teva since 2003, holding various positions in commercial supply chain and global logistics. Bertil holds a a degree in International Trade and Wholesalers and a BSc. in Business Management.Back
Noa Anker is Head of API Manufacturing & Supply Operations in Teva’s Global Operations team.
Noa has held a wide range of positions in the manufacturing, engineering and quality teams during her successful Teva career. She joined Teva in 2003 as a process engineer. During this time, she served as head of quality for the former Teva api and Biologics organization; site general manager for Teva Tech, and in several other leadership roles including head of AMSO operations, production manager and quality assurance leader.
Noa holds a Bachelor of Science degree in chemical engineering from Ben-Gurion University in Israel.
Teva api is a stand-alone business unit within Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer and one of the 15 largest pharmaceutical companies worldwide.
The rich history of Teva api dates back to 1935 with the founding of Assia, a company that specialized in the production of veterinary and pharmaceutical ingredients. Over the years, Teva api has acquired and established top-rated manufacturing and development facilities around the world. Each facility goes through a comprehensive integration program to align with the company’s high standards and best practices.
Today Teva api operates 15 production plants and 6 R&D centers across the globe. Each facility contributes to our ongoing excellence in research and development, production and customer service.
Pliva Croatia Ltd. PbF site R&DAddress
Prilaz baruna Filipovića 25,
CroatiaEstablished 1935Acquired by Teva api 2007
Pliva Croatia Ltd. SM site ManufacturingAddress
Savski Marof site at the business address: Prudnička Cesta 54, 10291, Prigorje Brdovečko
Tel + 385 1 37 20 000Fax + 385 1 37 20 111Established 1878Acquired by Teva api 2008
Teva Czech Industries s.r.o. R&D ManufacturingAddress
Opava, Komárov, Ostravská 29
Indication number 305
Postal code 747 70, Czech RepublicEstablished 1883 (Galena)Acquired by Teva api 2006
Debrecen site R&D ManufacturingAddress
Pallagi út 13.
HungaryEstablished 1952 (Biogal)Acquired by Teva api 1995
Sajobabony site ManufacturingAddress
Vegyipari Park (Industrial Area)
P.O. Box 6, HungaryEstablished 2005
Caronno site ManufacturingAddress
Via Enrico Fermi n. 520 -21042
Caronno Pertusella (VA)Tel +39 02 964421Established 1975 (I.C.F.I)Acquired by Teva api 2002
Rho site R&D ManufacturingAddress
77 - 20017 Rho (MI)Tel +39 02 931971Acquired by Teva api 2004
Santhia site ManufacturingAddress
Tenuta S. Alessandro
13048 Santhià (VC)Tel +39 0161 936600Established 1983Acquired by Teva api 2004
Villanterio site ManufacturingAddress
S.S. 235 Km 16,600
27019 Villanterio (PV)Tel +39 0382 963501
Teva API B.V. Regional OfficeAddress
Piet Hein Building
Piet Heinkade 107
1019 GM Amsterdam
The NetherlandsTel +31-0-20-2193-222
Teva API B.V. Regional OfficeAddress
Rau James Joule 92-90 Andar
CEP 04576-080 Sao Paulo
Sicor de Mexico S.A. de C.V. ManufacturingAddress
Av. San Rafael No. 35,
Col. Parque Industrial Lerma,
Lerma de Villada,
Estado de México, C.P. 52000 Mexico
Teva API Inc. Regional OfficeAddress
400 Interpace Parkway
Parsippany NJ 07054
USATel +1-9732653600Fax +1-9732653681
Teva API B.V. Regional OfficeAddress
Gemdale Plaza Block B,
Gajraula site ManufacturingAddress
Plot. Nos. A-1, A-1/1 & A-1/2 UPIDC Industrial Area. Bijnor Road, Distt.J.P.Nagar
1444235 Gajraula (Uttar Pradesh)
IndiaTel 05924252591-92-93Fax 05924252590Established 1994 (JK Pharmaceutical)Acquired by Teva api 2003
Malanpur site ManufacturingAddress
Plot Nos. Q1 - Q4 Industrial Area, Ghirongi, District-Bhind, Malanpur 477 117 (Madhya Pradesh)
IndiaTel 07539 - 283942Established 2008
Teva API India Private Limited R&DAddress
2-G, 2-H, 2-I Eco Tech – II, Udyog Vihar
201 306 (Uttar Pradesh)
IndiaTel +91-120-4073300Fax +91-120-4073275
Teva Pharmaceutical & Chemical Industries India Pvt. Ltd. Regional OfficeAddress
Office no. 8A, 8th floor, Tower C
Times Square Bldg
Andheri Kurla Road, Gamdevi, Marol
Andheri East, Mumbai - 400059
Maharashtra IndiaTel +91 22 62685555Fax +91 22 62685990
Watson Pharma Private Limited ManufacturingAddress
Ambernath Site: Plot no N 15, Additional Ambernath, Anand nagar MIDC. Ambernath East Dist. Thane, 421506, Maharashtra, IndiaTel +02512626000
Teva Tech ManufacturingAddress
Neot Hovav Eco-Industrial Park, Emek Sara; P.O. Box 2049 Be’er Sheva, 8412316, IsraelTel +972-8-6509555Fax +972-8-6509500
Assia Chemical Industries Ltd. R&DAddress
Hatrufa 12 st.,
P.O. Box 8077
Teva Pharmaceutical Industries Ltd. Regional OfficeAddress
124 Devorah Haneviaa St.
Tel Aviv 6944020,
Teva API Japan Ltd Regional OfficeAddress
7F, 5-1-5, Toranomon
JapanTel +81-354048441Fax +81-354048442Acquired by Teva api 2002
- Regional offices